Plain-English translation of NCT06429735 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The PRIME Study is testing a new device called the Neuralink N1 Implant, which is surgically placed in the brain using a robotic surgical system. This wireless implant has tiny electrode threads that connect to brain cells and may allow paralyzed people to control computers, robotic limbs, or other devices just by thinking. This is one of the first studies in humans to see if this technology is safe and actually works.
People with severe paralysis from spinal cord injury or ALS often lose the ability to move their arms and hands, even though their brains still work normally. This trial exists to explore whether a brain-computer interface can bridge that gap and give people back some control over their environment and devices.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo brain surgery to have the N1 Implant and its electrode threads placed in your brain using the robotic surgical system. After surgery, you would work with the research team to learn how to use the implant to control external devices through your thoughts. You would attend follow-up visits so doctors can monitor your safety, measure how well the device works, and adjust it as needed.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States